慢性肾脏病中肾脏线粒体功能障碍的显像:[99mTc]Tc-MIBI SPECT/CT 的再利用作用
本研究将心肌灌注显像剂[99mTc]Tc-MIBI再利用于肾脏功能显像,纳入11例新诊断慢性肾脏病(CKD)患者和27名匹配健康志愿者行动态肾扫描及SPECT/CT,评估肾脏线粒体功能障碍。CKD患者肾[99mTc]Tc-MIBI摄取百分比和SUV均显著低于健康志愿者,平均SUV与肾活检线粒体含量正相关,且为CKD的独立预测因子(OR 0.2,P=0.037),诊断准确性高(AUC=0.886),而传统生物标志物预测价值有限。
要点
- CKD患者动态肾扫描[99mTc]Tc-MIBI摄取百分比和SPECT/CT SUV均显著低于健康志愿者。
- 平均SUV与CKD患者肾活检线粒体含量呈正相关。
- 平均SUV为CKD独立预测因子(OR 0.2,P=0.037),AUC=0.886。
核心结论
- [99mTc]Tc-MIBI肾脏SPECT/CT可有效检测CKD患者的肾脏线粒体功能障碍,提示其作为无创影像生物标志物的潜力。
- SUV可作为评估肾脏线粒体功能障碍的定量参数。
研究设计与样本
- 研究纳入11例新诊断CKD患者和27名匹配健康志愿者,行[99mTc]Tc-MIBI动态肾扫描和SPECT/CT。
- 对左肾进行定量分析,评估时间-放射性曲线、肾脏摄取百分比和标准化摄取值(SUV)。
- 采用肾活检样本免疫组化评估CKD患者肾脏线粒体含量。
主要发现
- CKD患者eGFR与健康志愿者相当,但动态扫描肾[99mTc]Tc-MIBI摄取百分比显著降低,SPECT/CT SUV亦降低。
- CKD患者平均SUV与肾脏线粒体含量呈正相关。
- 平均SUV为CKD的独立预测因子(OR 0.2,P=0.037),诊断准确性高(AUC=0.886),而传统生物标志物预测价值有限。
关键数值与推荐
- 平均SUV预测CKD的OR为0.2(P=0.037),AUC为0.886。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: [99mTc]Tc-MIBI is a conventional myocardial perfusion radiotracer, and is predominantly taken up by mitochondria in a manner dependent on mitochondrial membrane potential. This study aimed to repurpose [99mTc]Tc-MIBI for functional renal imaging to evaluate mitochondrial dysfunction in chronic kidney disease (CKD). RESULTS: A total of 11 patients with newly diagnosed CKD and 27 matched healthy volunteers underwent [99mTc]Tc-MIBI dynamic renal scans and SPECT/CT. Quantitative analyses of the left kidneys assessed time-activity curves, percentage of renal uptake, and standardized uptake values (SUV). Renal mitochondrial content in CKD patients was evaluated using immunohistochemistry of kidney biopsy samples. CKD patients had comparable eGFR to healthy volunteers but exhibited significantly lower renal [99mTc]Tc-MIBI uptake percentage on dynamic scan and decreased SUV on SPECT/CT. A positive correlation was observed between mean SUV and renal mitochondrial content in CKD patients. Mean SUV was identified as an independent predictor of CKD (odds ratio 0.2, P = 0.037), demonstrating high diagnostic accuracy (AUC = 0.886), whereas conventional biomarkers had limited predictive value. CONCLUSIONS: [99mTc]Tc-MIBI kidney SPECT/CT effectively detected renal mitochondrial dysfunction in patients with CKD, suggests its potential as a noninvasive imaging biomarker. SUV may serve as a quantitative parameter for assessing renal mitochondrial dysfunction.
引用
- Park SB, Lim CH, Jin SY, et al. Imaging renal mitochondrial dysfunction in chronic kidney disease: a repurposed role for [99mTc]Tc-MIBI SPECT/CT. EJNMMI Res. 2025. PMID: 40892155. doi:10.1186/s13550-025-01306-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。